IRD

Conviction 51HealthcareScan · Fri, Jun 26, 2026

IRD$4.00+7.53%

ResistanceSupportVol 14Insider sell

Vol MA14 1.11M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Opus Genetics, Inc.PHARMACEUTICAL PREPARATIONSwww.opusgtx.com ↗

Price4.00

Change+7.53%

Gap+2.42%

Rel volume5.77×

Avg volume1.07M

Avg $ vol4.34M

SMA 204.04

SMA 504.59

SMA 2003.23

Price vs 50-12.82%

Price vs 200+23.98%

MA stackmixed

50/200 cross—

Supertrenddown · 4.56

RSI (14)46

MACD hist0.02

MACD crossbull · 6d

Stoch %K / %D57 / 23

ADX (14)16

+DI / −DI25 / 22

RSI divergence—

MACD divergence—

ATR %+7.40%

ADR %7.41%

52w high5.75

52w low0.9399

From 52w high-30.43%

Above 52w low+325.58%

New 52w highNo

SqueezeOn · 9d

Bollinger width19.68%

%B0.45

Donchian pos36.02%

Donchian high4.68

Donchian low3.62

AVWAP (52w high)4.55

vs AVWAP high-12.08%

AVWAP (52w low)3.41

vs AVWAP low+17.41%

OBV trendUp

Chaikin MF (20)-0.09

Today vs 20d5.77×

Avg vol (14d)1.11M

Avg vol (20d)1.07M

Avg $ vol (20d)4.34M

Market cap—

RS 3m (vs SPY)-33.48%

RS 6m (vs SPY)+73.36%

RS line new highNo

Trend template5/8

Technical rank63.8

1 week-1.72%

1 month-3.38%

3 months-11.50%

6 months+99.00%

1 year+312.29%

YTD+88.68%

P/E-6.11

P/B-6.61

P/S21.36

P/FCF-8.60

EPS-0.8000

Div yield—

ROE108.19%

ROA-74.25%

Debt/Eq-0.03

Current7.13

EV/EBITDA-6.34

Gross margin—

Net margin-349.33%

Rev growth29.15%

EPS growth13.80%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value244.44M

Revenue2.16M

Net income-65.53M

Gross profit—

Free cash flow-35.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out82.57M

Employees28

ListedFri, Nov 6, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction51 / 100

Pattern quality—

Tech rank63.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.38

Support3.82

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IRD

All disclosures →

No recent disclosed trades by Congress in IRD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IRD · 1 buy · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Foundation Fighting Blindness Retinal Degeneration Fund Director · Common Stock · 2026-05-18	Sell	1.7M	$7.4M	2026-05-18	2026-05-20
Foundation Fighting Blindness, Inc. Director · Common Stock · 2026-05-18	Sell	1.7M	$7.4M	2026-05-18	2026-05-20
SCHACHLE JOSEPH K Chief Operating Officer · Common Stock · 2026-04-23	Sell	4.7K	$25K	2026-04-23	2026-04-27
Magrath George Chief Executive Officer · Common Stock · 2026-04-23	Sell	9.51K	$50K	2026-04-23	2026-04-27
Jayagopal Ashwath Chief Scientific & Dev. Ofc. · Common Stock · 2026-04-23	Sell	7.54K	$39K	2026-04-23	2026-04-27
YERXA BENJAMIN R President · Common Stock · 2026-04-23	Sell	7.47K	$39K	2026-04-23	2026-04-27
Zaremba Rabourn Amy Head of Fin. Quality Assurance · Common Stock · 2026-04-23	Sell	1.64K	$9K	2026-04-23	2026-04-27
Gagnon Robert E. Chief Financial Officer · Common Stock · 2026-04-23	Sell	7.84K	$41K	2026-04-23	2026-04-27
Gallagher Cam Director · Common Stock · 2026-04-20	Other	—	—	2026-04-20	2026-04-22
Rodgers Richard J Director · Common Stock · 2026-04-20	Grant	24.37K	$0	2026-04-20	2026-04-22

SEC filings

EDGAR filings in IRD · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.